|
Site Search
|
SciGen Buys China Rights to Generex Oral Insulin Spray
publication date: Apr 14, 2008
SciGen, Ltd., a Singapore company that trades in Australia, has licensed the China rights to Oral-lyn™, an oral insulin spray product that is being developed by Generex. SciGen will supply its own recombinant human insulin product, while Generex will formulate and fill Generex Oral-lyn for marketing and distribution by SciGen in the territory. More details...
Stock Symbols: (ASX: SIE) (NSDQ: GNBT)
|
Partner Events
October 11-13, 2008
Dalian, China
U.S. FDA Inspections in China
October 15, 2008
China
November 8, 2008
San Diego, CA
November 9-11, 2008
Shanghai, China
February 23-25, 2009
San Diego
>> More details...
|
